Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection.
about
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein bindingActivity of carbapenems combined with clavulanate against murine tuberculosis.Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh modelEfficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.Concentration-effect relationship of ceftazidime explains why the time above the MIC is 40 percent for a static effect in vivo.Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae.
P2860
Q28353204-7569FE0C-FB0A-495C-B87E-9E472CD4E941Q35004912-08B4975C-4073-42C8-A0B5-3FD42EA52E9DQ35758849-F5529D51-A376-4F9F-BBEF-10AA1B9F0168Q37538764-F949A2B4-F05F-44AD-BC4F-68538F281090Q39557331-C02CC3F6-837A-4379-A48F-F410F7A1C963Q41879559-A0301DAF-4906-4B98-A8A8-20F0CF8C8643Q43111815-53A60D35-982D-4FCA-845A-9191826D2EEBQ43215544-C0045D8A-0466-4237-962B-6FF94C0E9ACEQ47647043-861C8240-4613-4270-BEC8-B3BAD8F389B0
P2860
Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Pharmacokinetic and pharmacody ...... and in experimental infection.
@ast
Pharmacokinetic and pharmacody ...... and in experimental infection.
@en
type
label
Pharmacokinetic and pharmacody ...... and in experimental infection.
@ast
Pharmacokinetic and pharmacody ...... and in experimental infection.
@en
prefLabel
Pharmacokinetic and pharmacody ...... and in experimental infection.
@ast
Pharmacokinetic and pharmacody ...... and in experimental infection.
@en
P2093
P2860
P1476
Pharmacokinetic and pharmacody ...... and in experimental infection.
@en
P2093
Douwes-Idema AE
van Strijen E
P2860
P304
P407
P577
1997-10-01T00:00:00Z